Structural & Congenital Heart Disease

Abbott plans to acquire Cephea Valve Technologies, a company developing a transcatheter mitral…
The University of Florida College of Veterinary Medicine has partnered with veterinary cardiologist…
The FDA has approved the Amplatzer Piccolo Occluder as a minimally invasive treatment option for…
Patients with atrial fibrillation can safely continue oral anticoagulation (OAC) while undergoing…
Adults with congenital heart disease (CHD) report better health-related quality of life (HRQoL)…
Almost 95 percent of patients survived 25 years after discharge for surgical repair of tetralogy of…
Developing an effective triage process for patients on the transcatheter aortic valve replacement (…
The Society of Cardiovascular Computed Tomography (SCCT) released updated guidelines for using CT…
The first United States patient has been treated with the J-Valve TF system designed to address one…
Ramping up the battle against cardiovascular disease in women represents a golden opportunity to…
Will operators be able to replicate COAPT’s restraint & its outcomes?
Three more executives resigned from Johns Hopkins All Children’s Hospital in St. Petersburg,…